US Stock MarketDetailed Quotes

ARWR Arrowhead Pharmaceuticals

Watchlist
  • 21.080
  • +0.640+3.13%
Close Feb 19 16:00 ET
  • 21.425
  • +0.345+1.64%
Post 17:56 ET
2.66BMarket Cap-4.09P/E (TTM)

Arrowhead Pharmaceuticals Key Stats

Arrowhead Pharmaceuticals Q1 2025 Earnings Date

Currency:USDFeb 10, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
19.05M
2.50M
-16.55M
Miss Est.
+436.47%
-29.60%
-86.88%
EPS
-0.38
-1.39
-1.01
Miss Est.
+69.26%
-12.10%
-264.64%
Buy

Feb 14, 2025

Arrowhead Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 40.814M--
--2025/Q2-- / 118.541M--
Feb 10, 20252025/Q12.500M / 19.050M--
Nov 26, 20242024/Q40.000 / 58.913M--
Aug 8, 20242024/Q30.000 / 37.142M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 40.814M--
--2025/Q2-- / 118.541M--
Feb 10, 20252025/Q12.500M / 19.050M--
Nov 26, 20242024/Q40.000 / 58.913M--
Aug 8, 20242024/Q30.000 / 37.142M--

Unlock Free Earnings Estimates

Arrowhead Pharmaceuticals Earnings Reports

Read more

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More